Drug Shortage Report for IRINOTECAN HYDROCHLORIDE INJECTION USP
Report ID | 223404 |
Drug Identification Number | 02357585 |
Brand name | IRINOTECAN HYDROCHLORIDE INJECTION USP |
Common or Proper name | IRINOTECAN HYDROCHLORIDE |
Company Name | ACCORD HEALTHCARE INC |
Market Status | MARKETED |
Active Ingredient(s) | IRINOTECAN HYDROCHLORIDE |
Strength(s) | 20MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 5ml |
ATC code | L01CE |
ATC description | |
Reason for shortage | Requirements related to complying with good manufacturing practices. |
Anticipated start date | 2024-06-30 |
Actual start date | 2024-07-05 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-07-06 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | Customer Service at (514) 505-4159 ext. 203 | Service à la clientèle à (514) 505-4159 poste 203 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2024-07-06 | English | Compare |
v5 | 2024-07-05 | French | Compare |
v4 | 2024-07-05 | English | Compare |
v3 | 2024-07-01 | English | Compare |
v2 | 2024-03-26 | French | Compare |
v1 | 2024-03-26 | English | Compare |
Showing 1 to 6 of 6